Results 31 to 40 of about 5,187 (196)

Oclusão arterial aguda por derivados da ergotamina Acute arterial occlusion caused by ergotamine derivatives

open access: yesJornal Vascular Brasileiro, 2009
Os derivados da ergotamina compõem diversas drogas amplamente utilizadas no tratamento de ataques agudos de migrânea. A intoxicação por estas substâncias resulta geralmente de sua administração crônica, promovendo sintomas secundários ao espasmo arterial
Edison Barreto de Souza   +1 more
doaj   +1 more source

Fluorimetric assay of ergotamine

open access: yes, 1974
Studies on the fluorescence properties of ergotamine in water at various pH values, and in several organic solvents are described. An assay procedure for ergotamine, based on its intense fluorescence in ethanol, is presented.
Sutherland J.M.   +3 more
core   +1 more source

Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence

open access: yesDrug Design, Development and Therapy, 2022
Dianna Liu,1 Shicheng Lin,2 Yuan Li,2 Tian Zhou,1 Kaiwen Hu,1 Quanwang Li1 1Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100071, People’s Republic of China; 2Graduate School, Beijing University of Chinese ...
Liu D, Lin S, Li Y, Zhou T, Hu K, Li Q
doaj  

A rare complication of coronary vasospasm associated with concomitant use of ergotamine, cobicistat, and darunavir

open access: yesAntiviral Therapy, 2022
Ergotism is a rare cause of peripheral vasoconstriction with varying presentation depending on the affected vessels. Coronary vasospasm is a rare, potentially fatal manifestation of ergotism.
Cheng-En Wu   +3 more
doaj   +1 more source

Colon Ischaemia Induced by Amoxicillin-related Anaphylactic Shock

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Colon ischaemia is the most frequent type of ischaemia of the digestive tract. It is more common among the elderly, especially patients with haemodynamic disturbance.
Nuno Melo   +4 more
doaj   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 14, Page 3970-3991, July 2026.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander   +5 more
wiley   +1 more source

Treatment of chronic orthostatic hypotension with ergotamine.

open access: yes, 1983
The acute and chronic effects of ergotamine were examined in four patients with chronic orthostatic hypotension. Chronic oral administration of ergotamine tartrate produced significant increases in standing blood pressure and marked clinical improvement,
M A Creager   +4 more
core   +1 more source

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 14, Page 3935-3949, July 2026.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

The Determination of Ergotamine in Preparations Containing Ergotamine Tartrate and Cyclizine Hydrochloride

open access: yes, 1962
Benzhydrol, an impurity in some samples of cyclizine hydrochloride, interferes with the colorimetric estimation of ergotamine in preparations containing ergotamine tartrate and cyclizine hydrochloride. A method for overcoming this difficulty is described.
B E Lawrence, A C Caws
core   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 14, Page 3897-3919, July 2026.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Home - About - Disclaimer - Privacy